Atlas Trials

A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

Clinical trial NCT05683340 · COMPLETED

Trial details

NCT number
NCT05683340
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyper-low-density Lipoprotein (LDL) Cholesterolemia
Start date
2023-02-13
Primary completion
2024-02-20
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.